Antiretroviral Therapy for Advanced HIV Disease in South Africa

PHASE4CompletedINTERVENTIONAL
Enrollment

1,771

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

August 31, 2008

Conditions
HIV
Interventions
DRUG

Zidovudine

600 mg once daily

DRUG

Stavudine

40 mg once daily

DRUG

Didanosine

\<60 kg/125 mg twice daily or \>60kg/200 mg twice daily

DRUG

Lamivudine

300 mg once daily

DRUG

Efavirenz

600 mg once daily

DRUG

Lopinavir/Ritonavir

r/LPV 400mg/100mg twice daily

Trial Locations (7)

Unknown

South African Military Health Services (SAMHS), Centurion

Umtata Sickbay, Eastaern Cape

3 Military Hospital, Free State

1 Military Hospital, Gauteng

Mtubatuba SIckbay, Kwazulu-Natal

Phalaborwa Sickbay, Limpopo

2 Military Hospital, Western Cape

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00342355 - Antiretroviral Therapy for Advanced HIV Disease in South Africa | Biotech Hunter | Biotech Hunter